Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II Trial of KRN7000 in Chronic Hepatitis B
NCT00363155Phase 2Completed
- Sponsor
- Foundation for Liver Research
- Start
- Mar 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of alpha-galactosylceramide in Chronic Hepatitis B (CHB) (3 arms), sponsored by Foundation for Liver Research. Primary endpoint: Safety and Tolerability. Started Mar 2003; status: completed.
02
Drugs
alpha-galactosylceramide
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT00363155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00363155.